-
Unveiling the Novel Anti - Tumor Potential of Digitonin, a Steroidal Saponin, in Gastric Cancer: A Network Pharmacology and Experimental Validation Study
05 Apr 2025 08:44 GMT
… properties.6–9 Digitonin, a steroidal saponin derived from the Digitalis … “GC”, “stomach neoplasms”, “digitonin”, and “steroidal saponin”. The intersection of GC … in colon cancer. Comput Struct Biotechnol J. 2022;20:5287–5295 …
-
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
08 Apr 2025 09:00 GMT
… the “Company”), a clinical-stage biotechnology company focused on developing innovative … step in advancing a non-steroidal, locally delivered treatment for oral … Pharmaceuticals is a clinical-stage biotechnology company focused on developing new …
-
Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
03 Apr 2025 22:58 GMT
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s …
-
AbbVie’s upadacitinib gains EU marketing authorisation for GCA
09 Apr 2025 10:03 GMT
… of the therapy plus a steroid taper regimen for 26 weeks … those on placebo with a steroid taper regimen.
AbbVie research and … amylin analogue, GUB014295, from Danish biotech Gubra.
Sign up for our …
-
Developmental And Epileptic Encephalopathies Market To Observe Stunning Growth During The Study Period (2020–2034) | Delveinsight
08 Apr 2025 17:21 GMT
… .1 Antiseizure medications 8.2 Steroid therapy 8.3 Other Therapies … Pharmaceuticals, Telix Pharmaceuticals, Shanghai Simnova Biotechnology, NEONC Technologies, among others. Epilepsy …
-
Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight
08 Apr 2025 17:00 GMT
… .1
Antiseizure medications
8.2
Steroid therapy
8.3
Other Therapies … Pharmaceuticals, Telix Pharmaceuticals, Shanghai Simnova Biotechnology, NEONC Technologies, among others. Epilepsy …
-
Mechanism Exploration of Dunyeguanxinning in the Treatment of Atherosclerosis Based on UPLC-Q-Orbitrap HRMS Technology, Network Pharmacology, Molecular Docking and Experimental Validation
08 Apr 2025 15:04 GMT
… purchased from Shanghai Tauto Biotech Co., Ltd. Accurately … is a water-soluble steroidal saponin extract from Dioscorea … main metabolic component of steroidal saponins from Dioscorea species. … sub-chronic toxicity of steroidal saponins from Dioscorea …
-
Huyang Yangkun Formula Enhances Ovarian Function and Delays Reproductive Aging by Influencing Hypothalamic GnRH/LH Pulse Release Through GAT-1/GABA/GABAAR2
08 Apr 2025 15:05 GMT
… were provided by Wuhan Huamei Biotechnology Company.
RT-qPCR
The frozen … The aging reproductive neuroendocrine axis. Steroids. 2005;70(4):273–283 … doi:10.1016/j.steroids.2004.12.008
4. Dai … , a comparative perspective. J Steroid Biochem mol Biol. 2014;142 …
-
Johnson & Johnson Highlights New Data, Demonstrating Long-Term Sustained Disease Control In Adults Living With Generalised Myasthenia Gravis (Gmg)
08 Apr 2025 10:39 GMT
… to decrease or discontinue their steroid useAdditionally, the nipocalimab plus standard … Research & Development, LLC, Janssen Biotech, Inc. Janssen-Cilag International NV … & Development, LLC, Janssen Biotech, Inc. Janssen-Cilag International NV …
-
Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia gravis (gMG)
08 Apr 2025 07:27 GMT
… to decrease or discontinue their steroid use
Additionally, the … amp; Development, LLC and Janssen Biotech, Inc. are Johnson & … & Development, LLC, Janssen Biotech, Inc. and/or … & Development, LLC, Janssen Biotech, Inc. nor Johnson & …
About
© 1995-2025